Project Details
Description
PROJECT SUMMARY
Immunotherapies, and specifically immune-checkpoint inhibitors, are revolutionizing the therapeutic paradigm
for several solid tumors. To date, however, the response to these drugs in patients with castration resistance
prostate cancer (CRPC) has been modest, despite that a vaccine therapy, sipuleucel-T, has been approved
based on survival data. Several hypotheses have been proposed to explain this intrinsic resistance, including
an immunosuppressive prostate tumor microenvironment. Diet modifications have been reported to impact
tumorigenesis and tumor progression, including prostate cancer models. Dietary restriction of methionine has
been shown to extend the lifespan of rodents, to reduce inflammation in healthy animals and to enhance
metabolic activity. Sulfur containing amino acids such as methionine and cystine are precursors for thiols and
critical for several cellular processes including immune system. Results from our lab have shown that dietary
protein restriction significantly decreases tumor growth in preclinical models of castration resistant prostate
cancer. The inhibition of tumor growth is associated with reduction of tumor infiltrating macrophages with M2,
immunosuppressive phenotype. Our preliminary data also show that methionine restriction induces in vitro
polarization of bone marrow-derived macrophages to a M1, immunopromoting phenotype. Thus, there is a
rationale to determine the role of dietary protein modification and, in particular methionine restriction, on
modulating the immune response in prostate cancer.
Our central hypothesis is that reduction in dietary protein intake may have a significant impact on prostate
cancer by modifying the immunosuppressive microenvironment and enhancing innate and adaptive immune
response. The principal objective of this proposal is to exploit the role of diet intervention in the treatment of
prostate cancer in the setting of immunotherapies.
Specific Aims: To achieve our goal we will pursue the following specific aims: 1) To assess the impact of
dietary protein or methionine restriction on the prostate tumor microenvironment both in vitro and in vivo; 2) To
determine the impact of protein diet modification or methionine restriction on prostate tumor response to
immunotherapies
The proposed study is highly innovative by introducing diet modifications as an adjuvant treatment in in
prostate cancer. Our proposed studies will determine how altered amino acid diets may enhance the response
to immunotherapeutic treatments. This will contribute to the scientific field by advancing knowledge of diet and
CaP/cancer in general with a focus of advancing immunotherapeutic treatments. Translation of this research
may provide novel less invasive and more appealing adjuvant treatments for CaP patients.
| Status | Finished |
|---|---|
| Effective start/end date | 01/5/21 → 08/31/23 |
Funding
- National Cancer Institute: $123,123.16
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.